“NANO WORM DISEASE EXPOSED” AMERICANS VS CHEMTRAILS
THOUSANDS NOW INFECTED WITH NANO WORMS IN THE USA, ENVIRONMENTAL SCIENTISTS HAVE LINKED THE INFECTIONS WITH CHEMTRAILS.
So far 10 Environmental Scientists have been murdered after releasing lab test results linking chemtrails to the mass death of fish, plant and animal life. Shehla Masood, Ruben Santana Alonso, Thongnak Sawekchinda, Sandra Viviana Cuellar Gallego, Eugene Franklin Mallove, Prajob Nao-opas, Sombath Somphone, José Cláudio Ribeiro da Silva, Joao Chupel Primo and Maria do Espirito Santo.
VIDEO PROOF BELOW!!!
NEW DISEASE NOW KNOWN AS CHEMTRAIL NANO WORMS EXPOSED
Morgellons disease seems to be found primarily in people with RH negative blood type. This is currently being studied at 4 major universities in the USA. One mystery remains as to the origin of blood type RH-. It has been concluded by science that this blood type couldn’t have come from our normal understanding of evolution, but why hasn’t this information been revealed to the general public? where did the RH- blood type come from? Where did the RH- blood type come from if not evolution?.
Morgellons and NANO-worms same disease with different names. The following info about nano-worms was first published in 2008.
In a joint research project, scientists from the University of California, San Diego, the University of California, Santa Barbara, and the Massachusetts Institute of Technology, have designed and created tiny ‘nanoworms’. These miniature devices can be navigated through blood vessels without triggering a significant immune response and therefore, can be used as a means for non-invasive cancer treatment, as it will be possible to reach cancerous cells from within the body.
While the idea of using specific nano-particles to target tumors is not new, the nanoworms are a completely new invention, and have remarkable advantages over spherical nano-particles.
The researchers synthesized the nanoworms by coating spherical nano- particles of iron oxide with a polysaccharide called dextran. The coated nano-particles aggregated in a linear fashion, essentially creating ‘nanoworms’. Each nanoworm is 30 nano-meters long, making it about 3 million times smaller than an earthworm.
“The reason that these worms work so well is due to a combination of their shape and to a polymer coating on their surface that allows the nanoworms to evade these natural elimination processes,” said Michael Sailor, a Professor of chemistry and biochemistry at UC San Diego who led the research team. “As a result, our nanoworms can circulate in the body of a mouse for many hours.”
During their travels in the bloodstream, the nanoworms reach nearly every organ and tissue in the body. In order to make sure they concentrate mainly at the site of the tumor, the researchers coated the nano-worms with a tumor-specific targeting molecule. This peptide, called F3, which allows the nanoworms to home in on tumors, was developed in the laboratory of Erkki Ruoslahti, a cell biologist and professor at the Burnham Institute for Medical Research at UC Santa Barbara.
“Because of its elongated shape, the nano-worm can carry many F3 molecules that can simultaneously bind to the tumor surface,” said Sailor. “And this cooperative effect significantly improves the ability of the nanoworm to attach to a tumor.”
The scientists were able to verify that their nanoworms homed in on tumor sites by injecting them into the bloodstreams of mice with tumors. They found that the nanoworms had indeed aggregated in the tumors, although a major uptake of nanoworms by the liver was also noticeable. Unlike spherical nano-particles of similar size that were shuttled out of the blood stream by the immune system, the nanoworms remained mice’s in the bloodstream for hours.
“This is an important property because the longer these nano-worms can stay in the bloodstream, the more chances they have to hit their targets, the tumors,” said Ji-Ho Park, a UC San Diego graduate student in materials science and engineering, who is working in Sailor’s laboratory. Park was the motivating force behind the discovery when he found by accident that the gummy worm aggregates of nano-particles exhibited long-lasting retention time in the bloodstream.
Despite the good results, the researchers are well aware that the current design can still be improved. Since the nanoworms aggregate in the liver as well as at the tumor sites, they cannot be optimal carriers for the anti- cancerous drugs just yet. In order to deal with this problem, the researchers are currently working on other molecules and drugs that can be attached to the nanoworms and should increase their specificity and functionality.
“We are now using nanoworms to construct the next generation of smart tumor-targeting nano-devices,” said Ruoslahti. “We hope that these devices will improve the diagnostic imaging of cancer and allow pinpoint targeting of treatments into cancerous tumors.”
Other researchers involved in the development of the nanoworms are Michael Schwartz of UC San Diego, Geoffrey von Maltzahn of MIT, and Lianglin Zhang of UC Santa Barbara. The project was funded by grants from the National Cancer Institute of the National Institutes of Health.
TFOT has recently reported on drug-coated nano-particles, used to fight cancer more efficiently. Nano-particles were also surveyed as a catalyst for fuel-cell cars.
More information about the nano-worms can be found on the University of California, San Diego website.
CHEMTRAILS CHEMTRAIL CHEM-TRAIL CHEM-TRAILS AEROSOL SPRAY SPRAYING SKY HARD METAL ALUMINUM BARIUM MERCURY NANO WORM WORMS NANO-WORMS RH NEGATIVE BLOOD TYPE MORGELLONS DISEASE CDC FDA ALEX JONES VENTURA JESSE